.rahmen1 {
border: 3px solid rgb(220,126,72);
border-radius: 5px;
padding: 10px;
}

About this Workshop

The pharma industry is undergoing a significant transformation due to digital technologies. Techniques such as visualization, modeling, automation, machine learning and artificial intelligence are dematerializing traditional processes and facilities, and drive productivity through fewer errors, higher output and improved quality, safety and speed of operations.

Building on the success of the workshop in November 2018, ISPE D/A/CH will organize a second workshop on 4-5 June 2020 in Basel, Switzerland.

The event will feature case studies, regulatory aspects, opportunities, successes and pitfalls faced in the digitalization journey, pointing to the urgency to accelerate the digital transformation.

Unique to this workshop is that nine pharmaceutical manufacturers (Bayer, GSK, Johnson & Johnson, Merck, Novartis, Novo Nordisk, Roche, Sandoz and Takeda) will present and discuss their digital strategies and experiences.

This event is tailored for mid-senior level management, decision makers, and leaders who set strategy and direction for manufacturing, quality and CMC regulatory affairs in their organizations.
Event language: english.

Chair: Viktor Mettler, Global Quality Head REFS, NBS & Country Quality, Novartis,
           ISPE DACH Chapter representative
Co-Chair: Ursula Busse, Global Head Quality Intelligence & External Affairs, Novartis

Agenda

Download Agenda (PDF)

When?

4th to 5th of June, 2020

Where?

Virtual Online

Participation fee (digital online)

ISPE Members: 450 Euros
Non Members: 750 Euros

Could we spark your interest?

Contact: ISPE D/A/CH Secretary Rolf Sopp (rolf.sopp(at)ispe-dach.org)